The Wall Street Journal reported on Wednesday that India is in talks to buy 50 million doses of Pfizer Inc’s COVID-19 vaccine from German partner BioNTech SE, citing people familiar with the subject. The government has been depending primarily on the AstraZeneca vaccine made by the Serum Institute of India and a home-grown shot produced […]Continue Reading
